Showing results (1381-1390 of 1,401) with videos related to

Sort By:
Pageof 141
Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
Plos Genetics|April 26, 2014
Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemicLaura A Cotton, Xiaomei T Kuang, Anh Q Le, et al.
Scientific Data|November 22, 2025
Twenty years (2000-2020) of butterfly monitoring data across the contiguous United StatesErica H Henry, Collin B Edwards, Vaughn Shirey, et al.
The Journal of Clinical Investigation|November 13, 2012
HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolatesR Brad Jones, Keith E Garrison, Shariq Mujib, et al.
Nature Medicine|June 27, 2006
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencingRoman K Thomas, Elizabeth Nickerson, Jan F Simons, et al.
AIDS (London, England)|December 22, 2022
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapyHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Nature|March 11, 2021
Improving reporting standards for polygenic scores in risk prediction studiesHannah Wand, Samuel A Lambert, Cecelia Tamburro, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapyZabrina L Brumme, Francis Mwimanzi, Hope R Lapointe, et al.
Scientific Reports|April 19, 2018
Novel HLA class I associations with HIV-1 control in a unique genetically admixed populationHumberto Valenzuela-Ponce, Selma Alva-Hernández, Daniela Garrido-Rodríguez, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2022
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responsesHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Pageof 141